OCGN Latest News, Press Relases and Analysis

All

Press Releases

14 days ago - By: Ocugen

Ocugen CEO to Present at NobleCon21—Noble Capital Markets’ Twenty-First Annual Emerging Growth Equity Conference

14 days ago - By: Ocugen

Ocugen CEO to Present at NobleCon21—Noble Capital Markets’ Twenty-First Annual Emerging Growth Equity Conference

a month ago - By: The Motley Fool

Ocugen (OCGN) Q3 2025 Earnings Call Transcript

a month ago - By: Zacks Investment Research - Mentions: KMDA

Ocugen (OCGN) Reports Q3 Loss, Beats Revenue Estimates

a month ago - By: Ocugen

Ocugen Provides Business Update with Third Quarter 2025 Financial Results

a month ago - By: Benzinga - Mentions: TECH INSE GEF SKYT ...

Earnings Scheduled For November 5, 2025

3 months ago - By: Benzinga

Forecasting The Future: 4 Analyst Projections For Ocugen

a month ago - By: Ocugen

Ocugen Provides Business Update with Third Quarter 2025 Financial Results

a month ago - By: Ocugen

Ocugen to Host Webcast on Wednesday, November 5 at 8:30 A.M. ET to Discuss Business Updates and Third Quarter 2025 Financial Results

a month ago - By: Ocugen

Ocugen to Host Webcast on Wednesday, November 5 at 8:30 A.M. ET to Discuss Business Updates and Third Quarter 2025 Financial Results

2 months ago - By: Ocugen

Ocugen to Present at Industry and Investor Conferences in October 2025

4 months ago - By: The Motley Fool

Ocugen (OCGN) Q2 Revenue Jumps 20%

2 months ago - By: Ocugen

Ocugen to Present at Industry and Investor Conferences in October 2025

3 months ago - By: Ocugen

Ocugen, Inc. and Kwangdong Pharmaceutical Co., Ltd. Complete License Agreement of OCU400 Modifier Gene Therapy for Retinitis Pigmentosa in Korea

3 months ago - By: Ocugen

Ocugen, Inc. and Kwangdong Pharmaceutical Co., Ltd. Complete License Agreement of OCU400 Modifier Gene Therapy for Retinitis Pigmentosa in Korea

3 months ago - By: Ocugen

Ocugen to Participate in H.C. Wainwright 27th Annual Global Investment Conference & Biotech on Tap 2025

3 months ago - By: Ocugen

Ocugen to Participate in H.C. Wainwright 27th Annual Global Investment Conference & Biotech on Tap 2025

3 months ago - By: Zacks Investment Research

Ocugen (OCGN) Upgraded to Buy: Here's What You Should Know

4 months ago - By: Ocugen

Ocugen, Inc. Announces Positive Scientific Advice from the European Medicines Agency Related to the Approval Pathway for OCU410ST—Modifier Gene Therapy for Stargardt Disease

4 months ago - By: Ocugen

Ocugen, Inc. Announces Positive Scientific Advice from the European Medicines Agency Related to the Approval Pathway for OCU410ST—Modifier Gene Therapy for Stargardt Disease

4 months ago - By: Ocugen

Ocugen, Inc. Announces Closing of $20 Million Registered Direct Offering of Common Stock and Warrants

4 months ago - By: Ocugen

Ocugen, Inc. Announces Closing of $20 Million Registered Direct Offering of Common Stock and Warrants

4 months ago - By: Ocugen

Ocugen, Inc. Announces $20 Million Registered Direct Offering of Common Stock and Warrants

4 months ago - By: Ocugen

Ocugen, Inc. Announces $20 Million Registered Direct Offering of Common Stock and Warrants

4 months ago - By: Zacks Investment Research - Mentions: CCCC

Ocugen (OCGN) Reports Q2 Loss, Misses Revenue Estimates

4 months ago - By: Ocugen

Ocugen Provides Business Update with Second Quarter 2025 Financial Results

4 months ago - By: Ocugen

Ocugen Provides Business Update with Second Quarter 2025 Financial Results

5 months ago - By: Ocugen

Ocugen, Inc. Announces New Appointments to Retina Scientific Advisory Board & Executive Leadership Team

5 months ago - By: Ocugen

Ocugen, Inc. Announces New Appointments to Retina Scientific Advisory Board & Executive Leadership Team

5 months ago - By: Ocugen

Ocugen, Inc. Announces First Patient Dosed in Phase 2/3 GARDian3 Pivotal Confirmatory Trial for OCU410ST—Novel Modifier Gene Therapy Candidate for Stargardt Disease

5 months ago - By: Ocugen

Ocugen, Inc. Announces First Patient Dosed in Phase 2/3 GARDian3 Pivotal Confirmatory Trial for OCU410ST—Novel Modifier Gene Therapy Candidate for Stargardt Disease

OCUGEN INC (OCGN) Stock News

OCGN Latest News, Press Relases and Analysis